메뉴 건너뛰기




Volumn 9, Issue 4, 2011, Pages 1169-1188

Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPYRIDINES; CHARACTERISATION; DE NOVO DESIGN; DRUG DISCOVERY; DRUG TARGETS; FATTY ACID OXIDATION; IN-SILICO; IN-VITRO; INDOLE COMPOUNDS; LIPID METABOLISMS; METABOLIC SYNDROMES; NOVEL SERIES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; POTENTIAL DRUG; TYPE II;

EID: 79551672505     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/c0ob00146e     Document Type: Article
Times cited : (21)

References (67)
  • 1
    • 10644247658 scopus 로고    scopus 로고
    • Metabolic Syndrome
    • A. M. Rouhi Metabolic Syndrome C & E News 2004 83
    • (2004) C & e News , pp. 83
    • Rouhi, A.M.1
  • 34
    • 0028036120 scopus 로고
    • The Molecular Operating Environment (MOE) available under license from Chemical Computing Group Inc., 1010 Sherbrooke St. W. Suite 910, Montreal, Quebec, Canada H3A 2R7
    • R. S. Bohacek C. McMartin J. Am. Chem. Soc. 1994 116 5560
    • (1994) J. Am. Chem. Soc. , vol.116 , pp. 5560
    • Bohacek, R.S.1    McMartin, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.